Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$161.01 - $317.85 $121,240 - $239,341
753 Added 2.94%
26,356 $8.34 Million
Q3 2023

Nov 14, 2023

SELL
$164.66 - $218.08 $551,611 - $730,568
-3,350 Reduced 11.57%
25,603 $4.33 Million
Q2 2023

Aug 14, 2023

BUY
$176.32 - $240.22 $634,575 - $864,551
3,599 Added 14.19%
28,953 $6.28 Million
Q1 2023

May 15, 2023

SELL
$161.33 - $204.36 $238,929 - $302,657
-1,481 Reduced 5.52%
25,354 $4.61 Million
Q4 2022

Feb 14, 2023

SELL
$191.53 - $236.82 $84,464 - $104,437
-441 Reduced 1.62%
26,835 $5.27 Million
Q3 2022

Nov 14, 2022

BUY
$123.79 - $277.42 $548,265 - $1.23 Million
4,429 Added 19.39%
27,276 $6.14 Million
Q2 2022

Aug 15, 2022

SELL
$93.97 - $143.33 $550,006 - $838,910
-5,853 Reduced 20.39%
22,847 $2.89 Million
Q2 2021

Aug 12, 2021

BUY
$107.45 - $135.95 $795,130 - $1.01 Million
7,400 Added 34.74%
28,700 $3.27 Million
Q1 2021

May 17, 2021

SELL
$95.46 - $133.08 $362,748 - $505,704
-3,800 Reduced 15.14%
21,300 $2.56 Million
Q4 2020

Feb 03, 2021

SELL
$75.23 - $109.23 $308,443 - $447,843
-4,100 Reduced 14.04%
25,100 $2.55 Million
Q3 2020

Nov 16, 2020

BUY
$71.31 - $109.74 $848,589 - $1.31 Million
11,900 Added 68.79%
29,200 $2.26 Million
Q2 2020

Aug 12, 2020

BUY
$62.14 - $117.21 $62,140 - $117,210
1,000 Added 6.13%
17,300 $1.93 Million
Q1 2020

May 06, 2020

BUY
$60.41 - $115.92 $567,854 - $1.09 Million
9,400 Added 136.23%
16,300 $1.17 Million
Q4 2019

Feb 14, 2020

BUY
$11.44 - $123.99 $78,936 - $855,531
6,900 New
6,900 $520,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.